A significant breakthrough in cancer investigation is emerging with the use of nanobodies to re-engage mutated p53. This vital tumor inhibitor protein is frequently disabled in several forms of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research